FTRECongressional Stock Trades
Fortrea Holdings Inc. Common Stock
Services-Medical Laboratories
Congressional stock trades in Fortrea Holdings Inc. Common Stock (FTRE) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
1
Politicians Trading
1
Last Traded
Jun 23, 2025
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| J. French HillR | Jul 24, 2025 | Jun 23, 2025 | Sell | $1,001 - $15,000 | +290.78% |
Price History
About Fortrea Holdings Inc. Common Stock
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.